BioAge Labs, Inc.

Bioage Labs, Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Richmond, CA, United States • BIOA (NMS)

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

510 806 1445 1445A South 50th Street, Richmond, CA 94804, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher? - The Motley Fool
The Motley Fool • Oct 26
BioAge Labs (NASDAQ:BIOA) Sets New 52-Week High - Still a Buy? - MarketBeat
MarketBeat • Dec 24
2 Reasons I Wouldn't Touch BioAge Labs Stock With a 10-Foot Pole - Yahoo Finance
Yahoo Finance • Dec 13
Can BioAge Labs Inc. stock deliver sustainable ROE - Portfolio Diversification Tips & Turn Bull Runs into Life-Changing Wealth - bollywoodhelpline.com
bollywoodhelpline.com • Dec 28
BioAge Labs (BIOA) Price Target Increased by 24.14% to 12.24 - Nasdaq
Nasdaq • Dec 20

Other Drug Manufacturers - Specialty & Generic Companies

View All →
Elanco Animal Health Inc logo Elanco Animal Health Inc.
1 layoff tracked
$11.23B market cap
Zoetis Inc. logo Zoetis Inc.
$55.83B market cap
Galderma Group AG/ADR logo Galderma Group AG
$49.28B market cap
TAKEDA PHARMACEUTICAL CO LTD logo Takeda Pharmaceutical Co. Ltd.
$47.02B market cap
Haleon plc logo Haleon PLC
$44.93B market cap
TEVA PHARMACEUTICAL INDUSTRIES LTD logo TEVA Pharmaceutical Industries Ltd.
$32.82B market cap

Frequently Asked Questions

Has BioAge Labs, Inc. had layoffs?
No layoff events have been recorded for BioAge Labs, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does BioAge Labs, Inc. have?
BioAge Labs, Inc. has approximately 62 employees.
What industry is BioAge Labs, Inc. in?
BioAge Labs, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.
Is BioAge Labs, Inc. a publicly traded company?
Yes, BioAge Labs, Inc. is publicly traded under the ticker symbol BIOA on the NMS. The company has a market capitalization of approximately $0.50 billion.
Where is BioAge Labs, Inc. headquartered?
BioAge Labs, Inc. is headquartered in Richmond, CA, United States at 1445A South 50th Street, Richmond, CA 94804, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.